Insights

Additional Insights

Publications

• Brandt SJ, Müller TD, DiMarchi RD, Tschöp MH, Stemmer K. (2018) Peptide-based multi-agonists: a new paradigm in metabolic pharmacology. Journal of internal medicine 284(6), 581-602.
• Brandt SJ, Gotz A, Tschop MH, Muller TD (2018) Gut hormone polyagonists for the treatment of type 2 diabetes. Peptides 100: 190-201.
• Brandt SJ, Mayer JP, Ford J, Gelfanov VM, DiMarchi RD (2018) Controlled intramolecular antagonism as a regulator of insulin receptor maximal activity. Peptides 100: 18-23.
• Sanchez-Garrido MA, Brandt SJ, Clemmensen C, Muller TD, DiMarchi RD, Tschop MH (2017) GLP-1/glucagon receptor co-agonism for treatment of obesity. Diabetologia 60 1851-1861.